Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: A4HQ91
Term | Name | Level | Count |
---|---|---|---|
GO:0001522 | pseudouridine synthesis | 6 | 11 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 11 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 11 |
GO:0006807 | nitrogen compound metabolic process | 2 | 11 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0009451 | RNA modification | 5 | 11 |
GO:0009987 | cellular process | 1 | 11 |
GO:0016070 | RNA metabolic process | 5 | 11 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 11 |
GO:0043170 | macromolecule metabolic process | 3 | 11 |
GO:0043412 | macromolecule modification | 4 | 11 |
GO:0044237 | cellular metabolic process | 2 | 11 |
GO:0044238 | primary metabolic process | 2 | 11 |
GO:0046483 | heterocycle metabolic process | 3 | 11 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:0090304 | nucleic acid metabolic process | 4 | 11 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 11 |
GO:0006396 | RNA processing | 6 | 9 |
GO:0006399 | tRNA metabolic process | 7 | 9 |
GO:0008033 | tRNA processing | 8 | 9 |
GO:0034470 | ncRNA processing | 7 | 9 |
GO:0034660 | ncRNA metabolic process | 6 | 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 11 |
GO:0003723 | RNA binding | 4 | 11 |
GO:0003824 | catalytic activity | 1 | 11 |
GO:0005488 | binding | 1 | 11 |
GO:0009982 | pseudouridine synthase activity | 4 | 11 |
GO:0016853 | isomerase activity | 2 | 11 |
GO:0016866 | intramolecular transferase activity | 3 | 11 |
GO:0097159 | organic cyclic compound binding | 2 | 11 |
GO:1901363 | heterocyclic compound binding | 2 | 11 |
GO:0106029 | tRNA pseudouridine synthase activity | 5 | 1 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 1 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 1 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 226 | 230 | PF00656 | 0.285 |
CLV_C14_Caspase3-7 | 626 | 630 | PF00656 | 0.527 |
CLV_C14_Caspase3-7 | 66 | 70 | PF00656 | 0.502 |
CLV_NRD_NRD_1 | 202 | 204 | PF00675 | 0.289 |
CLV_NRD_NRD_1 | 207 | 209 | PF00675 | 0.286 |
CLV_NRD_NRD_1 | 28 | 30 | PF00675 | 0.449 |
CLV_NRD_NRD_1 | 474 | 476 | PF00675 | 0.195 |
CLV_NRD_NRD_1 | 512 | 514 | PF00675 | 0.411 |
CLV_PCSK_KEX2_1 | 100 | 102 | PF00082 | 0.581 |
CLV_PCSK_KEX2_1 | 167 | 169 | PF00082 | 0.561 |
CLV_PCSK_KEX2_1 | 202 | 204 | PF00082 | 0.289 |
CLV_PCSK_KEX2_1 | 206 | 208 | PF00082 | 0.287 |
CLV_PCSK_KEX2_1 | 256 | 258 | PF00082 | 0.285 |
CLV_PCSK_KEX2_1 | 27 | 29 | PF00082 | 0.408 |
CLV_PCSK_KEX2_1 | 474 | 476 | PF00082 | 0.337 |
CLV_PCSK_KEX2_1 | 512 | 514 | PF00082 | 0.422 |
CLV_PCSK_PC1ET2_1 | 100 | 102 | PF00082 | 0.579 |
CLV_PCSK_PC1ET2_1 | 167 | 169 | PF00082 | 0.561 |
CLV_PCSK_PC1ET2_1 | 256 | 258 | PF00082 | 0.285 |
CLV_PCSK_PC7_1 | 202 | 208 | PF00082 | 0.289 |
CLV_PCSK_SKI1_1 | 160 | 164 | PF00082 | 0.536 |
CLV_PCSK_SKI1_1 | 173 | 177 | PF00082 | 0.462 |
CLV_PCSK_SKI1_1 | 257 | 261 | PF00082 | 0.362 |
CLV_PCSK_SKI1_1 | 311 | 315 | PF00082 | 0.408 |
CLV_PCSK_SKI1_1 | 364 | 368 | PF00082 | 0.416 |
CLV_PCSK_SKI1_1 | 384 | 388 | PF00082 | 0.266 |
CLV_PCSK_SKI1_1 | 424 | 428 | PF00082 | 0.285 |
CLV_PCSK_SKI1_1 | 512 | 516 | PF00082 | 0.388 |
CLV_PCSK_SKI1_1 | 566 | 570 | PF00082 | 0.388 |
CLV_PCSK_SKI1_1 | 589 | 593 | PF00082 | 0.241 |
DEG_APCC_DBOX_1 | 26 | 34 | PF00400 | 0.429 |
DEG_APCC_DBOX_1 | 379 | 387 | PF00400 | 0.408 |
DEG_APCC_DBOX_1 | 423 | 431 | PF00400 | 0.285 |
DEG_APCC_DBOX_1 | 521 | 529 | PF00400 | 0.401 |
DEG_APCC_KENBOX_2 | 224 | 228 | PF00400 | 0.285 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.581 |
DEG_SCF_FBW7_1 | 619 | 625 | PF00400 | 0.597 |
DEG_SPOP_SBC_1 | 119 | 123 | PF00917 | 0.594 |
DOC_CKS1_1 | 333 | 338 | PF01111 | 0.300 |
DOC_CKS1_1 | 601 | 606 | PF01111 | 0.488 |
DOC_CKS1_1 | 619 | 624 | PF01111 | 0.576 |
DOC_MAPK_DCC_7 | 311 | 321 | PF00069 | 0.195 |
DOC_MAPK_gen_1 | 254 | 261 | PF00069 | 0.285 |
DOC_MAPK_gen_1 | 27 | 33 | PF00069 | 0.444 |
DOC_MAPK_gen_1 | 378 | 387 | PF00069 | 0.422 |
DOC_MAPK_HePTP_8 | 375 | 387 | PF00069 | 0.335 |
DOC_MAPK_MEF2A_6 | 378 | 387 | PF00069 | 0.343 |
DOC_MAPK_NFAT4_5 | 380 | 388 | PF00069 | 0.335 |
DOC_PP1_RVXF_1 | 244 | 251 | PF00149 | 0.285 |
DOC_PP1_RVXF_1 | 397 | 404 | PF00149 | 0.405 |
DOC_PP2B_LxvP_1 | 334 | 337 | PF13499 | 0.195 |
DOC_PP2B_LxvP_1 | 530 | 533 | PF13499 | 0.285 |
DOC_PP4_FxxP_1 | 647 | 650 | PF00568 | 0.323 |
DOC_PP4_FxxP_1 | 662 | 665 | PF00568 | 0.330 |
DOC_USP7_MATH_1 | 119 | 123 | PF00917 | 0.672 |
DOC_USP7_MATH_1 | 158 | 162 | PF00917 | 0.547 |
DOC_USP7_MATH_1 | 323 | 327 | PF00917 | 0.437 |
DOC_USP7_MATH_1 | 455 | 459 | PF00917 | 0.196 |
DOC_USP7_MATH_1 | 47 | 51 | PF00917 | 0.352 |
DOC_USP7_MATH_1 | 623 | 627 | PF00917 | 0.620 |
DOC_USP7_MATH_1 | 94 | 98 | PF00917 | 0.744 |
DOC_WW_Pin1_4 | 319 | 324 | PF00397 | 0.282 |
DOC_WW_Pin1_4 | 325 | 330 | PF00397 | 0.269 |
DOC_WW_Pin1_4 | 332 | 337 | PF00397 | 0.241 |
DOC_WW_Pin1_4 | 413 | 418 | PF00397 | 0.441 |
DOC_WW_Pin1_4 | 499 | 504 | PF00397 | 0.399 |
DOC_WW_Pin1_4 | 600 | 605 | PF00397 | 0.498 |
DOC_WW_Pin1_4 | 618 | 623 | PF00397 | 0.482 |
LIG_14-3-3_CanoR_1 | 210 | 216 | PF00244 | 0.238 |
LIG_14-3-3_CanoR_1 | 257 | 262 | PF00244 | 0.285 |
LIG_14-3-3_CanoR_1 | 384 | 394 | PF00244 | 0.353 |
LIG_APCC_ABBA_1 | 221 | 226 | PF00400 | 0.285 |
LIG_BIR_III_4 | 304 | 308 | PF00653 | 0.362 |
LIG_BIR_III_4 | 37 | 41 | PF00653 | 0.530 |
LIG_BRCT_BRCA1_1 | 278 | 282 | PF00533 | 0.362 |
LIG_BRCT_BRCA1_1 | 94 | 98 | PF00533 | 0.477 |
LIG_BRCT_BRCA1_2 | 94 | 100 | PF00533 | 0.480 |
LIG_EH1_1 | 453 | 461 | PF00400 | 0.285 |
LIG_FHA_1 | 129 | 135 | PF00498 | 0.530 |
LIG_FHA_1 | 152 | 158 | PF00498 | 0.456 |
LIG_FHA_1 | 360 | 366 | PF00498 | 0.298 |
LIG_FHA_1 | 581 | 587 | PF00498 | 0.419 |
LIG_FHA_1 | 601 | 607 | PF00498 | 0.440 |
LIG_FHA_1 | 619 | 625 | PF00498 | 0.376 |
LIG_FHA_1 | 654 | 660 | PF00498 | 0.256 |
LIG_FHA_2 | 161 | 167 | PF00498 | 0.564 |
LIG_FHA_2 | 267 | 273 | PF00498 | 0.408 |
LIG_FHA_2 | 279 | 285 | PF00498 | 0.408 |
LIG_FHA_2 | 292 | 298 | PF00498 | 0.149 |
LIG_FHA_2 | 513 | 519 | PF00498 | 0.300 |
LIG_FHA_2 | 54 | 60 | PF00498 | 0.454 |
LIG_FHA_2 | 546 | 552 | PF00498 | 0.408 |
LIG_HCF-1_HBM_1 | 668 | 671 | PF13415 | 0.372 |
LIG_HP1_1 | 47 | 51 | PF01393 | 0.259 |
LIG_LIR_Apic_2 | 600 | 604 | PF02991 | 0.455 |
LIG_LIR_Apic_2 | 661 | 665 | PF02991 | 0.395 |
LIG_LIR_Gen_1 | 458 | 469 | PF02991 | 0.285 |
LIG_LIR_Gen_1 | 53 | 63 | PF02991 | 0.351 |
LIG_LIR_Gen_1 | 550 | 559 | PF02991 | 0.422 |
LIG_LIR_LC3C_4 | 641 | 645 | PF02991 | 0.235 |
LIG_LIR_Nem_3 | 416 | 421 | PF02991 | 0.278 |
LIG_LIR_Nem_3 | 458 | 464 | PF02991 | 0.422 |
LIG_LIR_Nem_3 | 53 | 58 | PF02991 | 0.356 |
LIG_LIR_Nem_3 | 550 | 555 | PF02991 | 0.373 |
LIG_LIR_Nem_3 | 580 | 584 | PF02991 | 0.408 |
LIG_MYND_1 | 332 | 336 | PF01753 | 0.300 |
LIG_NRBOX | 142 | 148 | PF00104 | 0.316 |
LIG_NRBOX | 382 | 388 | PF00104 | 0.195 |
LIG_PCNA_PIPBox_1 | 397 | 406 | PF02747 | 0.422 |
LIG_SH2_CRK | 552 | 556 | PF00017 | 0.408 |
LIG_SH2_CRK | 581 | 585 | PF00017 | 0.305 |
LIG_SH2_STAP1 | 34 | 38 | PF00017 | 0.362 |
LIG_SH2_STAP1 | 409 | 413 | PF00017 | 0.282 |
LIG_SH2_STAP1 | 552 | 556 | PF00017 | 0.422 |
LIG_SH2_STAP1 | 654 | 658 | PF00017 | 0.328 |
LIG_SH2_STAT5 | 354 | 357 | PF00017 | 0.408 |
LIG_SH2_STAT5 | 419 | 422 | PF00017 | 0.276 |
LIG_SH2_STAT5 | 437 | 440 | PF00017 | 0.272 |
LIG_SH2_STAT5 | 452 | 455 | PF00017 | 0.285 |
LIG_SH2_STAT5 | 55 | 58 | PF00017 | 0.455 |
LIG_SH3_3 | 130 | 136 | PF00018 | 0.578 |
LIG_SH3_3 | 326 | 332 | PF00018 | 0.378 |
LIG_SH3_3 | 525 | 531 | PF00018 | 0.305 |
LIG_Sin3_3 | 144 | 151 | PF02671 | 0.307 |
LIG_SUMO_SIM_anti_2 | 641 | 646 | PF11976 | 0.235 |
LIG_SUMO_SIM_par_1 | 29 | 37 | PF11976 | 0.414 |
LIG_SUMO_SIM_par_1 | 317 | 322 | PF11976 | 0.195 |
LIG_SUMO_SIM_par_1 | 47 | 53 | PF11976 | 0.289 |
LIG_SUMO_SIM_par_1 | 71 | 76 | PF11976 | 0.373 |
LIG_TRAF2_1 | 104 | 107 | PF00917 | 0.557 |
LIG_TRAF2_1 | 294 | 297 | PF00917 | 0.222 |
LIG_TRAF2_1 | 515 | 518 | PF00917 | 0.257 |
LIG_TRFH_1 | 647 | 651 | PF08558 | 0.334 |
LIG_UBA3_1 | 146 | 155 | PF00899 | 0.428 |
MOD_CDK_SPxxK_3 | 600 | 607 | PF00069 | 0.522 |
MOD_CK1_1 | 128 | 134 | PF00069 | 0.428 |
MOD_CK1_1 | 36 | 42 | PF00069 | 0.525 |
MOD_CK1_1 | 467 | 473 | PF00069 | 0.444 |
MOD_CK1_1 | 50 | 56 | PF00069 | 0.346 |
MOD_CK1_1 | 653 | 659 | PF00069 | 0.345 |
MOD_CK1_1 | 79 | 85 | PF00069 | 0.663 |
MOD_CK1_1 | 92 | 98 | PF00069 | 0.686 |
MOD_CK2_1 | 126 | 132 | PF00069 | 0.490 |
MOD_CK2_1 | 158 | 164 | PF00069 | 0.549 |
MOD_CK2_1 | 266 | 272 | PF00069 | 0.408 |
MOD_CK2_1 | 278 | 284 | PF00069 | 0.410 |
MOD_CK2_1 | 291 | 297 | PF00069 | 0.209 |
MOD_CK2_1 | 319 | 325 | PF00069 | 0.414 |
MOD_CK2_1 | 512 | 518 | PF00069 | 0.290 |
MOD_CK2_1 | 53 | 59 | PF00069 | 0.455 |
MOD_CK2_1 | 629 | 635 | PF00069 | 0.633 |
MOD_CK2_1 | 672 | 678 | PF00069 | 0.639 |
MOD_Cter_Amidation | 472 | 475 | PF01082 | 0.195 |
MOD_GlcNHglycan | 122 | 125 | PF01048 | 0.615 |
MOD_GlcNHglycan | 325 | 328 | PF01048 | 0.402 |
MOD_GlcNHglycan | 37 | 41 | PF01048 | 0.535 |
MOD_GlcNHglycan | 635 | 638 | PF01048 | 0.442 |
MOD_GlcNHglycan | 79 | 82 | PF01048 | 0.658 |
MOD_GlcNHglycan | 84 | 87 | PF01048 | 0.628 |
MOD_GlcNHglycan | 91 | 94 | PF01048 | 0.718 |
MOD_GSK3_1 | 319 | 326 | PF00069 | 0.236 |
MOD_GSK3_1 | 32 | 39 | PF00069 | 0.554 |
MOD_GSK3_1 | 360 | 367 | PF00069 | 0.291 |
MOD_GSK3_1 | 463 | 470 | PF00069 | 0.409 |
MOD_GSK3_1 | 484 | 491 | PF00069 | 0.221 |
MOD_GSK3_1 | 541 | 548 | PF00069 | 0.429 |
MOD_GSK3_1 | 618 | 625 | PF00069 | 0.524 |
MOD_GSK3_1 | 629 | 636 | PF00069 | 0.443 |
MOD_GSK3_1 | 650 | 657 | PF00069 | 0.463 |
MOD_LATS_1 | 240 | 246 | PF00433 | 0.408 |
MOD_N-GLC_1 | 211 | 216 | PF02516 | 0.416 |
MOD_N-GLC_1 | 672 | 677 | PF02516 | 0.447 |
MOD_NEK2_1 | 179 | 184 | PF00069 | 0.451 |
MOD_NEK2_1 | 241 | 246 | PF00069 | 0.336 |
MOD_NEK2_1 | 360 | 365 | PF00069 | 0.422 |
MOD_NEK2_1 | 385 | 390 | PF00069 | 0.245 |
MOD_NEK2_1 | 464 | 469 | PF00069 | 0.411 |
MOD_NEK2_1 | 484 | 489 | PF00069 | 0.352 |
MOD_NEK2_1 | 577 | 582 | PF00069 | 0.392 |
MOD_NEK2_1 | 77 | 82 | PF00069 | 0.629 |
MOD_NEK2_2 | 47 | 52 | PF00069 | 0.354 |
MOD_PIKK_1 | 4 | 10 | PF00454 | 0.541 |
MOD_PK_1 | 126 | 132 | PF00069 | 0.346 |
MOD_PK_1 | 20 | 26 | PF00069 | 0.498 |
MOD_PKA_1 | 206 | 212 | PF00069 | 0.409 |
MOD_PKA_1 | 512 | 518 | PF00069 | 0.408 |
MOD_PKA_2 | 206 | 212 | PF00069 | 0.297 |
MOD_PKA_2 | 266 | 272 | PF00069 | 0.375 |
MOD_PKA_2 | 467 | 473 | PF00069 | 0.405 |
MOD_PKA_2 | 512 | 518 | PF00069 | 0.349 |
MOD_PKB_1 | 206 | 214 | PF00069 | 0.317 |
MOD_Plk_1 | 20 | 26 | PF00069 | 0.448 |
MOD_Plk_1 | 267 | 273 | PF00069 | 0.361 |
MOD_Plk_1 | 283 | 289 | PF00069 | 0.260 |
MOD_Plk_1 | 484 | 490 | PF00069 | 0.422 |
MOD_Plk_1 | 589 | 595 | PF00069 | 0.317 |
MOD_Plk_1 | 672 | 678 | PF00069 | 0.575 |
MOD_Plk_2-3 | 629 | 635 | PF00069 | 0.478 |
MOD_Plk_4 | 190 | 196 | PF00069 | 0.394 |
MOD_Plk_4 | 283 | 289 | PF00069 | 0.195 |
MOD_Plk_4 | 455 | 461 | PF00069 | 0.303 |
MOD_Plk_4 | 50 | 56 | PF00069 | 0.368 |
MOD_Plk_4 | 629 | 635 | PF00069 | 0.474 |
MOD_Plk_4 | 654 | 660 | PF00069 | 0.372 |
MOD_Plk_4 | 94 | 100 | PF00069 | 0.480 |
MOD_ProDKin_1 | 319 | 325 | PF00069 | 0.282 |
MOD_ProDKin_1 | 332 | 338 | PF00069 | 0.319 |
MOD_ProDKin_1 | 413 | 419 | PF00069 | 0.441 |
MOD_ProDKin_1 | 499 | 505 | PF00069 | 0.399 |
MOD_ProDKin_1 | 600 | 606 | PF00069 | 0.493 |
MOD_ProDKin_1 | 618 | 624 | PF00069 | 0.481 |
TRG_DiLeu_BaEn_1 | 381 | 386 | PF01217 | 0.335 |
TRG_DiLeu_BaEn_1 | 478 | 483 | PF01217 | 0.408 |
TRG_DiLeu_BaEn_4 | 295 | 301 | PF01217 | 0.422 |
TRG_DiLeu_BaLyEn_6 | 133 | 138 | PF01217 | 0.515 |
TRG_DiLeu_LyEn_5 | 381 | 386 | PF01217 | 0.335 |
TRG_ENDOCYTIC_2 | 218 | 221 | PF00928 | 0.362 |
TRG_ENDOCYTIC_2 | 55 | 58 | PF00928 | 0.335 |
TRG_ENDOCYTIC_2 | 552 | 555 | PF00928 | 0.350 |
TRG_ENDOCYTIC_2 | 581 | 584 | PF00928 | 0.285 |
TRG_ER_diArg_1 | 206 | 208 | PF00400 | 0.306 |
TRG_ER_diArg_1 | 27 | 29 | PF00400 | 0.481 |
TRG_ER_diArg_1 | 511 | 513 | PF00400 | 0.412 |
TRG_NLS_MonoCore_2 | 99 | 104 | PF00514 | 0.489 |
TRG_Pf-PMV_PEXEL_1 | 28 | 32 | PF00026 | 0.393 |
TRG_Pf-PMV_PEXEL_1 | 512 | 517 | PF00026 | 0.403 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P912 | Leptomonas seymouri | 59% | 95% |
A0A0S4K0L8 | Bodo saltans | 23% | 67% |
A0A1X0NMC1 | Trypanosomatidae | 43% | 94% |
A0A3Q8IJ87 | Leishmania donovani | 76% | 100% |
A0A422NSE9 | Trypanosoma rangeli | 43% | 100% |
A4IDY9 | Leishmania infantum | 76% | 100% |
D0A420 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 41% | 99% |
E9AU09 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 75% | 100% |
O74343 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 32% | 100% |
Q08647 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 26% | 100% |
Q08DI8 | Bos taurus | 28% | 100% |
Q17426 | Caenorhabditis elegans | 25% | 100% |
Q4Q0I6 | Leishmania major | 75% | 100% |
Q5V1E6 | Haloarcula marismortui (strain ATCC 43049 / DSM 3752 / JCM 8966 / VKM B-1809) | 26% | 100% |
Q91VU7 | Mus musculus | 28% | 100% |
Q96PZ0 | Homo sapiens | 28% | 100% |
Q9H0K6 | Homo sapiens | 27% | 97% |
Q9VSK9 | Drosophila melanogaster | 26% | 93% |
V5BT95 | Trypanosoma cruzi | 43% | 92% |